Polyamyna develops microbicidal coating technology and antimicrobial fabrics that inhibit the growth of multi-drug-resistant pathogens in healthcare settings. Their solutions aim to reduce hospital-acquired infections and combat antimicrobial resistance, enhancing patient safety and healthcare outcomes.
Funding
$350K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare settings face a significant challenge in preventing the spread of hospital-acquired infections (HAIs) caused by multi-drug resistant pathogens. Conventional treatments are becoming increasingly ineffective due to antimicrobial resistance (AMR), leading to prolonged hospital stays, increased healthcare costs, and higher mortality rates. The need for continuous and sustainable antimicrobial technologies is critical to ensure patient safety and well-being.
Solution
Polyamyna develops and provides continuous defense technologies designed to combat healthcare infections and antimicrobial resistance. Their core offerings include microbicidal coating technology (**Keep Klear™**) that provides a continuously active transparent coating with a 7-day residual effect, and antimicrobial additive technology (**Micro Dome®**) engineered for seamless integration into various polymer matrices. These technologies empower manufacturers to create high-performance, antimicrobial-enhanced products without changing existing processes. Polyamyna's solutions aim to create cleaner surfaces, inhibit the growth of drug-resistant pathogens, and ultimately reduce the incidence of HAIs.
Target Audience
Polyamyna's primary customers include hospitals, healthcare facilities, and manufacturers of medical devices and equipment seeking to enhance infection control and reduce the risk of HAIs.
Features
- **Keep Klear™:** A continuously active transparent microbicidal coating technology with a 7-day residual effect.
- **Micro Dome®:** An antimicrobial additive technology engineered for seamless integration into various polymer matrices.
- Broad-spectrum antimicrobial activity against multi-drug resistant pathogens.
- Durable and long-lasting protection on treated surfaces.
- Customizable formulations for various applications and materials.
- Technologies designed to be integrated into existing manufacturing processes.